INSM Relative Valuation
INSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INSM is overvalued; if below, it's undervalued.
Historical Valuation
Insmed Inc (INSM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -10.49. The fair price of Insmed Inc (INSM) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 205.04 USD , Insmed Inc is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：205.04
Fair
Undervalued
-44.77
PE
1Y
3Y
5Y
Trailing
Forward
-51.76
EV/EBITDA
Insmed Inc. (INSM) has a current EV/EBITDA of -51.76. The 5-year average EV/EBITDA is -11.88. The thresholds are as follows: Strongly Undervalued below -29.35, Undervalued between -29.35 and -20.61, Fairly Valued between -3.14 and -20.61, Overvalued between -3.14 and 5.59, and Strongly Overvalued above 5.59. The current Forward EV/EBITDA of -51.76 falls within the Strongly Undervalued range.
-49.96
EV/EBIT
Insmed Inc. (INSM) has a current EV/EBIT of -49.96. The 5-year average EV/EBIT is -11.04. The thresholds are as follows: Strongly Undervalued below -27.56, Undervalued between -27.56 and -19.30, Fairly Valued between -2.78 and -19.30, Overvalued between -2.78 and 5.48, and Strongly Overvalued above 5.48. The current Forward EV/EBIT of -49.96 falls within the Strongly Undervalued range.
46.67
PS
Insmed Inc. (INSM) has a current PS of 46.67. The 5-year average PS is 18.16. The thresholds are as follows: Strongly Undervalued below -3.46, Undervalued between -3.46 and 7.35, Fairly Valued between 28.98 and 7.35, Overvalued between 28.98 and 39.79, and Strongly Overvalued above 39.79. The current Forward PS of 46.67 falls within the Strongly Overvalued range.
-97.78
P/OCF
Insmed Inc. (INSM) has a current P/OCF of -97.78. The 5-year average P/OCF is -13.25. The thresholds are as follows: Strongly Undervalued below -41.25, Undervalued between -41.25 and -27.25, Fairly Valued between 0.75 and -27.25, Overvalued between 0.75 and 14.75, and Strongly Overvalued above 14.75. The current Forward P/OCF of -97.78 falls within the Strongly Undervalued range.
-52.22
P/FCF
Insmed Inc. (INSM) has a current P/FCF of -52.22. The 5-year average P/FCF is -11.61. The thresholds are as follows: Strongly Undervalued below -30.29, Undervalued between -30.29 and -20.95, Fairly Valued between -2.26 and -20.95, Overvalued between -2.26 and 7.08, and Strongly Overvalued above 7.08. The current Forward P/FCF of -52.22 falls within the Strongly Undervalued range.
Insmed Inc (INSM) has a current Price-to-Book (P/B) ratio of 46.10. Compared to its 3-year average P/B ratio of 44.11 , the current P/B ratio is approximately 4.50% higher. Relative to its 5-year average P/B ratio of 30.47, the current P/B ratio is about 51.27% higher. Insmed Inc (INSM) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -9.83%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -10.41% , the current FCF yield is about -100.00% lower.
46.10
P/B
Median3y
44.11
Median5y
30.47
-2.05
FCF Yield
Median3y
-9.83
Median5y
-10.41
Competitors Valuation Multiple
The average P/S ratio for INSM's competitors is 9.49, providing a benchmark for relative valuation. Insmed Inc Corp (INSM) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 52.36%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of INSM increased by 196.99% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -14.06 to -32.97.
The secondary factor is the Revenue Growth, contributed 52.36%to the performance.
Overall, the performance of INSM in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Insmed Inc (INSM) currently overvalued or undervalued?
What is Insmed Inc (INSM) fair value?
How does INSM's valuation metrics compare to the industry average?
What is the current P/B ratio for Insmed Inc (INSM) as of Dec 05 2025?
What is the current FCF Yield for Insmed Inc (INSM) as of Dec 05 2025?
What is the current Forward P/E ratio for Insmed Inc (INSM) as of Dec 05 2025?